A Durable Response to Low-Dose Afatinib After Progression on Osimertinib in Advanced Epidermal Growth Factor Receptor (EGFR) L861Q-Mutated Lung Adenocarcinoma: A Case Report.
Saved in:
| Title: | A Durable Response to Low-Dose Afatinib After Progression on Osimertinib in Advanced Epidermal Growth Factor Receptor (EGFR) L861Q-Mutated Lung Adenocarcinoma: A Case Report. |
|---|---|
| Authors: | Higashi T; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN., Araya T; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN., Ueda T; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN., Hara R; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN., Takato H; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN., Kita T; Respiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN. |
| Source: | Cureus [Cureus] 2026 Apr 17; Vol. 18 (4), pp. e107260. Date of Electronic Publication: 2026 Apr 17 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.107260 |
